BEDFORD, Mass., May 06, 2024 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s […]
EPS of $0.09, Adjusted EBITDA of $12.7 millionElectrical Systems revenues up 1.9% year-over-year despite a softening in end marketsReaffirming full-year […]